Stockhouse Ticker Trax is published to subscribers every Monday (annual cost only $195). We focus on best-in-class high growth small companies trading on the TSX and TSX.V between 5 cents and $3 with a market cap below $300 million.
Equity Analyst Danny Deadlock has 30 years of experience speculating on Canadian penny stocks and targets capital gain opportunities and diversification in metals and minerals exploration, energy, and technology.
For the experienced investor, Ticker Trax provides an extra set of eyes and ears (idea generation) and for those learning to invest in micro cap stocks, we provide stock picks and market education.
Subscribers receive; (1) new research (stock picks) weeks in advance of being featured on this weekend column (2) exclusive access to our list of junior gold exploration companies (critical for peer valuation), (3) exclusive access to our list of Cash Rich micro cap companies (our Virtual Vulture Fund) which contains 80 companies with almost $3 Billion.
Both tables are updated monthly.
In 2015 I am hunting for promising opportunities outside of resource exploration that will provide diversification with strong capital gain potential.
Sirona Biochem Corp. (TSX: V.SBM, Stock Forum) has a lot in the pipeline that could have a big impact on share price in 2015. But this type of stock is very difficult to buy on good news. Case in point - July 31, 2014 Sirona announced successful synthesis of an anti-inflammatory compound for their Bloom Burton joint venture.
At the time I would have viewed this as good news but not "great" news. The stock over the next three days gained 50% on 20 million shares of buying! It came back over time because of this lousy market but it shows how quickly these biotech micro cap stocks can move.
When you are finished reading my report I think you will recognize the same potential I see for multiple avenues of high impact news over the next year or two.
In particular are licensing deals with big pharmaceutical or cosmetic companies. These can not only produce initial payments worth several hundred million dollars, but ongoing royalties worth even more.
These are the type of licensing agreements we will be speculating on (hoping for) with Sirona. The current market cap is only $15 million so there is plenty of room for growth.
I tried to shorten my report length from fourteen pages but there is too much relevant information that needs to be properly digested. It is a detailed report but it will help you understand the risk/reward opportunity.
Click Here for Full Report in PDF format
** TWITTER NOTE: I maintain a twitter page at - twitter.com/tsxalerts
_________________________________________________________________________
Disclosure: Danny Deadlock owns 200,000 shares of SBM purchased in 2014
_________________________________________________________________________